 |
pembrolizumab |
|---|---|
| Trade Name | Keytruda |
| Orphan Indication | Merkel cell cancer |
| USA Market Approval | USA |
| USA Designation Date | 2016-12-28 00:00:00 |
| Sponsor | Merck, Sharp, and Dohme Corp.;1 Merck Access Road;New Jersey, 08889 |
Related Access Program
| |
pembrolizumab |
|---|---|
| Trade Name | Keytruda |
| Orphan Indication | Merkel cell cancer |
| USA Market Approval | USA |
| USA Designation Date | 2016-12-28 00:00:00 |
| Sponsor | Merck, Sharp, and Dohme Corp.;1 Merck Access Road;New Jersey, 08889 |